Drugs to fight bone thinning double cancer risk
September 3rd, 2010 - 4:47 pm ICT by IANSLondon, Sep 3 (IANS) Hundreds of thousands of women taking drugs to reverse bone thinning could be doubling their oesophagus (gut) cancer risk.
A major study shows those taking bisphosphonate (a class of drugs used to strengthen bone) drugs for five years, the recommended duration to improve bone strength, are at highest risk, but any level of use was linked to excess risk.
Around 1.4 million British women are eligible for treatment because of osteoporosis, but a quarter do not respond or suffer crippling stomach side-effects, reports the Daily Mail.
Patients can avoid these symptoms by taking their pills on empty stomach and stay upright for 30 minutes before eating and drinking, say doctors.
It is thought that gastric reflux, where stomach acid flows back up the food pipe, may cause precancerous changes, according to the British Medical Journal.
Researchers from the University of Oxford’s cancer epidemiology unit and the Medicines and Healthcare Products Regulatory Agency (MHRA) looked at the use of oral bisphosphonates, including Fosamax, and three types of cancer.
For those taking the drugs for at least three years - five years on average - the risk was more than double compared with those who had never taken them.
Typically, oesophageal cancer develops in one per 1,000 people aged 60 to 79 years over five years. Five years’ use of the drugs would push this up to two cases per 1,000.
- Bone Strenghthening Drugs Increases Throat Cancer Risk, Study Reveals - Sep 07, 2010
- Osteoporosis drug 'doubles cancer risk' - Sep 03, 2010
- Long-term use of osteoporosis drugs raises risk of fractures - Feb 23, 2011
- Bone loss drugs may cut breast cancer risk - Mar 03, 2010
- FDA dissociates Fosamax from fractures - Mar 12, 2010
- Osteoporosis drugs can raise fracture risk - Oct 17, 2010
- Drug counters bone-damaging effects of breast cancer medication - Oct 10, 2011
- 'Sponge on a string' can check oesophageal cancer risk - Sep 10, 2010
- Keep tab on osteoporosis pain-reliever: Experts (Oct 20 is World Osteoporosis Day) - Oct 19, 2011
- Pathology tests give cancer cells a miss - Mar 02, 2011
- UK wants to offer new cancer drugs before clearances - Dec 05, 2011
- Modified bone drug kills malaria parasite - Feb 28, 2012
- Common bone drugs may cut colon cancer risk - Feb 16, 2011
- Cancer safety fears of most common heartburn treatment rejected - Sep 10, 2009
- Long-term use of osteoporosis drug may weaken bones - Mar 11, 2010
Tags: bisphosphonates, bone strength, british medical journal, british women, cancer epidemiology unit, cancer risk, daily mail, empty stomach, excess risk, food pipe, fosamax, healthcare products regulatory agency, medicines and healthcare products regulatory agency, medicines and healthcare products regulatory agency mhr, precancerous changes, reflux, stomach acid, taking drugs, types of cancer, university of oxford